Research ArticleArticle
Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes
Iñigo Rúa-Figueroa, Francisco J. López-Longo, Víctor Del Campo, María Galindo-Izquierdo, Esther Uriarte, Julián Torre-Cisneros, Paloma Vela, Eva Tomero, Javier Narváez, Alejandro Olivé, Mercedes Freire, Eva Salgado, José Luis Andreu, Víctor Martínez-Taboada, Jaime Calvo-Alén, Blanca Hernández-Cruz, Enrique Raya, Víctor Quevedo, Lorena Expósito Pérez, Antonio Fernández-Nebro, Mónica Ibañez, Èlia Pascual-Valls, David Rúa-Figueroa, Antonio Naranjo and José M. Pego-Reigosa
The Journal of Rheumatology April 2019, jrheum.180882; DOI: https://doi.org/10.3899/jrheum.180882
Iñigo Rúa-Figueroa
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Francisco J. López-Longo
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Víctor Del Campo
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
María Galindo-Izquierdo
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Esther Uriarte
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Julián Torre-Cisneros
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Paloma Vela
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Eva Tomero
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Javier Narváez
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Alejandro Olivé
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Mercedes Freire
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Eva Salgado
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
José Luis Andreu
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Víctor Martínez-Taboada
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Jaime Calvo-Alén
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Blanca Hernández-Cruz
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Enrique Raya
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Víctor Quevedo
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Lorena Expósito Pérez
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Antonio Fernández-Nebro
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Mónica Ibañez
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Èlia Pascual-Valls
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
David Rúa-Figueroa
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Antonio Naranjo
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
José M. Pego-Reigosa
From the Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria, Las Palmas; Department of Rheumatology, Gregorio Marañón University Hospital, Madrid; Department of Preventive Medicine, University Hospital Complex, and Department of Rheumatology, Biomedical Research Institute of Vigo, Vigo; Department of Rheumatology, Doce de Octubre University Hospital, Madrid; Department of Rheumatology, Donostia Hospital, Guipuzcoa; Infectious Diseases Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba; Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University, Alicante; Department of Rheumatology, La Princesa University Hospital, Madrid; Department of Rheumatology, Bellvitge Hospital, Barcelona; Department of Rheumatology, Germans Trías i Pujol University Hospital, Badalona; Department of Rheumatology, University Hospital of A Coruña, A Coruña; Department of Rheumatology, University Hospital Complex of Ourense, Ourense; Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital, Majadahonda; Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University, Santander; Department of Rheumatology, University Hospital Araba, Victoria; Department of Rheumatology, Virgen Macarena Hospital, Seville; Department of Rheumatology, San Cecilio Hospital, Granada; Department of Rheumatology, Monforte Hospital, Lugo; Department of Rheumatology, Tenerife Clinic Hospital, Tenerife; Department of Rheumatology, Carlos Haya Hospital, Málaga; Department of Rheumatology, Son Llatzer Hospital, Palma de Mallorca; Department of Rheumatology, Doctor Peset Hospital, Valencia; University of Las Palmas, Gran Canaria, Las Palmas, Spain. This work was supported by the Spanish Foundation of Rheumatology. J.M. Pego-Reigosa is supported by grant 316265 (BIOCAPS) from the European Union 7th Framework Programme (FP7/ REGPOT-2012-2013.1) and FIS/ISCIII-Fondo Europeo de Desarrollo regional (grant number PI11/02857). I. Rúa-Figueroa, MD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; F.J. López-Longo, MD, PhD, Department of Rheumatology, Gregorio Marañón University Hospital; V. Del Campo, MD, PhD, Department of Preventive Medicine, University Hospital Complex, Biomedical Research Institute of Vigo; M. Galindo-Izquierdo, MD, PhD, Department of Rheumatology, Doce de Octubre University Hospital; E. Uriarte, MD, Department of Rheumatology, Donostia Hospital, J. Torre-Cisneros, MD, PhD, Infectious Diseases Department, IMIBIC, Reina Sofia University Hospital, University of Córdoba; P. Vela, MD, PhD, Department of Rheumatology, General University Hospital of Alicante, Miguel Hernandez University Alicante; E. Tomero, MD, Department of Rheumatology, La Princesa University Hospital; J. Narváez, MD, PhD, Department of Rheumatology, Bellvitge Hospital; A. Olivé, MD, PhD, Department of Rheumatology, Germans Trías i Pujol University Hospital; M. Freire, MD, Department of Rheumatology, University Hospital of A Coruña; E. Salgado, MD, PhD, Department of Rheumatology, University Hospital Complex of Ourense; J.L. Andreu, MD, PhD, Department of Rheumatology, Puerta del Hierro-Majadahonda University Hospital; V. Martínez-Taboada, MD, PhD, Department of Rheumatology, Marqués de Valdecilla University Hospital, Cantabria University; J. Calvo-Alén, MD, PhD, Department of Rheumatology, University Hospital Araba; B. Hernández-Cruz, MD, PhD, Department of Rheumatology, Virgen Macarena Hospital; E. Raya, MD, Department of Rheumatology, San Cecilio Hospital; V. Quevedo, MD, Department of Rheumatology, Monforte Hospital; L. Expósito Pérez, PhD, Department of Rheumatology, Tenerife Clinic Hospital; A. Fernández-Nebro, MD, PhD, Department of Rheumatology, Carlos Haya Hospital; M. Ibañez, MD, Department of Rheumatology, Son Llatzer Hospital; È. Pascual-Valls, MD, Department of Rheumatology, Doctor Peset Hospital; D. Rúa-Figueroa, MD, University of Las Palmas; A. Naranjo, MD, PhD, Department of Rheumatology, Doctor Negrín University Hospital of Gran Canaria; J.M. Pego-Reigosa, Department of Rheumatology, University Hospital Complex, Biomedical Research Institute of Vigo. Address correspondence to Dr. I. Rua-Figueroa, Rheumatology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Bco. De La Ballena s/n, 35011-Las Palmas de G. Canaria, Spain. E-mail: iruafer@gobiernodecanarias.org. Accepted for publication March 26, 2019.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes
Iñigo Rúa-Figueroa, Francisco J. López-Longo, Víctor Del Campo, María Galindo-Izquierdo, Esther Uriarte, Julián Torre-Cisneros, Paloma Vela, Eva Tomero, Javier Narváez, Alejandro Olivé, Mercedes Freire, Eva Salgado, José Luis Andreu, Víctor Martínez-Taboada, Jaime Calvo-Alén, Blanca Hernández-Cruz, Enrique Raya, Víctor Quevedo, Lorena Expósito Pérez, Antonio Fernández-Nebro, Mónica Ibañez, Èlia Pascual-Valls, David Rúa-Figueroa, Antonio Naranjo, José M. Pego-Reigosa
The Journal of Rheumatology Apr 2019, jrheum.180882; DOI: 10.3899/jrheum.180882
Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes
Iñigo Rúa-Figueroa, Francisco J. López-Longo, Víctor Del Campo, María Galindo-Izquierdo, Esther Uriarte, Julián Torre-Cisneros, Paloma Vela, Eva Tomero, Javier Narváez, Alejandro Olivé, Mercedes Freire, Eva Salgado, José Luis Andreu, Víctor Martínez-Taboada, Jaime Calvo-Alén, Blanca Hernández-Cruz, Enrique Raya, Víctor Quevedo, Lorena Expósito Pérez, Antonio Fernández-Nebro, Mónica Ibañez, Èlia Pascual-Valls, David Rúa-Figueroa, Antonio Naranjo, José M. Pego-Reigosa
The Journal of Rheumatology Apr 2019, jrheum.180882; DOI: 10.3899/jrheum.180882